Lactiplantibacillus plantarum/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases natural killer cell activity
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Specifically, NK cell activity, the primary endpoint, showed consistent increases across all effector-to-target (E:T) ratios in the HT-LM1004 group compared with the placebo group in both ITT and PP analyses.”
Quoted verbatim from Microbiome-Modulating Effects of Heat-Treated Lactiplantibacillus plantarum LM1004 and Its Enhancement of NK Cell Activity: Evidence from a Clinical Trial and a Simulated Human Intestinal Microbiome Ecosystem.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- one 500 mg capsule daily after dinner for 8 weeks
- Population
- Healthy adults aged 19-75 with a Perceived Stress Scale score of 16 or more, a white cell count of 3-10 x 10^3 per microlitre and at least two upper respiratory infections in the previous year; intention-to-treat and per-protocol analyses; maltodextrin placebo capsule in the comparator arm
Microbiome-Modulating Effects of Heat-Treated Lactiplantibacillus plantarum LM1004 and Its Enhancement of NK Cell Activity: Evidence from a Clinical Trial and a Simulated Human Intestinal Microbiome Ecosystem.2026PMID:42487409Industry fundedPermalink
Keep reading
- Everything the graph holds on Lactiplantibacillus plantarum
- Every compound studied against Natural killer cell activity
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45XA8H1VBGAJDEQXG5X45D4